TRUST-AI Governance Framework

USDM’s proprietary seven-pillar governance architecture — designed specifically for life sciences AI.
Aligned to FDA CSA, EU AI Act Articles 9–15, ISO 42001, NIST AI RMF, and GAMP 5 Second Edition.
Click each pillar to explore requirements and USDM capabilities.

Transparent — Explainability & Disclosure

AI systems in GxP environments must have documented, auditable decision logic. Regulators and auditors expect to understand how AI outputs are generated — and companies must be able to explain AI-driven decisions in human-interpretable terms. USDM implements explainability frameworks that satisfy FDA and EU AI Act Article 13 disclosure requirements.

Model card documentation and intended use statements
Audit trail integrity for all AI-assisted decisions
Regulatory-ready explainability reports for inspectors
Output confidence scoring with human review thresholds
XAI SOP (SOP-AI-028) — explainable AI documentation standard
Reliable — Performance Validation & Monitoring

AI systems must perform as intended — consistently, repeatably, and within defined boundaries. USDM applies FDA CSA risk-based validation principles to establish performance baselines, validate AI outputs, and maintain ongoing monitoring for drift and degradation across the model lifecycle.

orange-check
AI/ML system performance baseline documentation
orange-check
Risk-based validation strategy aligned to FDA CSA
orange-check
LLM output validation for GxP-adjacent generative AI applications
orange-check
Continuous monitoring for model drift and performance degradation
orange-check
IQ/OQ/PQ adapted for AI — GAMP 5 Category 5 approach
Unbiased — Fairness & Data Integrity

AI models trained on biased or non-ALCOA+ compliant data don’t just produce bad predictions — in a GxP context, they can generate biased outputs that influence regulatory submissions, patient safety decisions, and quality judgments. USDM’s bias assessment methodology addresses both algorithmic fairness and data integrity at the foundation.

purple-check
Training data lineage documentation and ALCOA+ alignment
purple-check
AI-readiness data foundation assessment (pre-deployment gate)
purple-check
Data governance framework supporting AI data quality requirements
purple-check
Bias detection methodology across protected and clinical attributes
purple-check
Ongoing bias monitoring integrated with model performance tracking
Secure — Data Protection & Cyber Controls

AI systems introduce novel cybersecurity risks — LLM data leakage, prompt injection, model poisoning, and adversarial attacks — on top of existing GxP data security requirements. USDM integrates AI-specific cybersecurity controls with your existing GxP security framework and regulatory data integrity obligations.

red-check
AI-specific data classification and access control framework
red-check
Third-party AI vendor security assessment (TPRM integration)
red-check
GxP audit trail requirements for AI-generated and AI-influenced records
red-check
LLM prompt injection and data leakage prevention controls
red-check
Integration with SOC 2 / ISO 27001 / HIPAA control frameworks
Tested — Validation Evidence & Quality

Tested AI is validated AI — with documented evidence that the system performs as intended under all conditions relevant to its GxP use. USDM applies structured testing methodologies adapted from FDA CSA and GAMP 5 to produce inspection-ready validation packages for AI systems of every risk classification.

green-check
Risk-based test strategy adapted for AI/ML systems
green-check
User acceptance testing framework for LLM output quality
green-check
Change control integration for model updates and retraining events
green-check
Automated regression testing via ProcessX for GxP AI workflows
green-check
Validation summary report and periodic review protocol
Accountable — Governance, Oversight & Human Control

Human oversight is non-negotiable for high-risk AI in life sciences. EU AI Act Articles 14–15 and FDA’s AI/ML guidance both require documented human-in-the-loop controls, clear accountability structures, and formal governance mechanisms. USDM establishes the operating model that makes accountability real — not just documented.

purple-2-check
AI Governance Committee charter and operating model
purple-2-check
Human-in-the-loop design requirements for GxP AI decisions
purple-2-check
AI incident response and escalation protocol
purple-2-check
Role-based accountability matrix (RACI) for AI systems
purple-2-check
Board-level AI risk posture reporting cadence and templates
Iterative — Continuous Improvement & Lifecycle Refinement

AI systems should not remain static after deployment — especially in regulated environments where performance, risk, and business context evolve over time. USDM applies a controlled lifecycle approach to continuously refine AI systems through testing, monitoring, feedback, and governed updates so improvements are captured without compromising compliance, validation status, or operational integrity.

check-iterative
Continuous improvement framework for AI/ML and LLM-based systems
check-iterative
Structured feedback loops for users, SMEs, and quality stakeholders
check-iterative
Governed model tuning, prompt refinement, and retraining change control
check-iterative
Periodic performance review tied to risk, drift, and business outcomes
check-iterative
Lifecycle refinement process aligned to validation and ongoing compliance
AI Maturity Assessment — 6 Dimensions
Strategy & Vision
L3
Governance & Policy
L3
Data & Infrastructure
L3
Talent & Culture
L3
Deployment & Operations
L3
Ethics & Risk Management
L3
AI Governance Maturity Levels
1
Initial — Ad hoc; no defined AI policies or controls
2
Developing — Emerging awareness; siloed AI initiatives underway
3
Defined — Documented processes; cross-functional governance forming
5
Managed — Measured, monitored; proactive AI risk management
4
Optimizing — Continuous improvement; AI innovation at enterprise scale
Assessment Deliverables
Maturity scorecard
Executive readiness brief
Peer benchmark comparison
90-day prioritized action roadmap
Use case pipeline with ROI estimates
Governance gap register
Regulatory Framework Alignment
FDA CSA + AI/ML
Risk-based validation, critical thinking documentation, performance monitoring
EU AI Act
High-risk classification, Annex IV documentation, conformity assessment
ISO 42001 / NIST
AI management systems, risk treatment, organizational accountability
GAMP 5 2nd Ed.
Category 5 AI/ML guidance, data integrity, life cycle management